Haverford, PA, United States of America

James Leyden


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: James Leyden: Innovator in Dermatological Treatments

Introduction

James Leyden is a notable inventor based in Haverford, Pennsylvania. He has made significant contributions to the field of dermatology, particularly in the treatment of skin conditions associated with steroid use. His innovative approach has led to the development of a patent that addresses a common issue faced by many patients.

Latest Patents

James Leyden holds a patent for the "Reduction of cutaneous atrophy." This patent focuses on ameliorating the cutaneous atrophy associated with the topical use of steroids through the use of salts of certain alpha-hydroxy acids. This invention represents a significant advancement in dermatological treatments, providing relief to patients suffering from skin thinning due to steroid application.

Career Highlights

Leyden is affiliated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work at this esteemed organization has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development in dermatology.

Collaborations

Throughout his career, James Leyden has worked alongside notable colleagues such as Prakash V Parab and Robert Lavker. These collaborations have enriched his research and have played a crucial role in the advancement of his patented innovations.

Conclusion

James Leyden's contributions to dermatology through his patent on the reduction of cutaneous atrophy highlight his commitment to improving patient care. His work continues to influence the field and offers hope for those affected by skin conditions related to steroid use.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…